Elevation Oncology, Inc.

NASDAQ:ELEV

0.3051 (USD) • At close June 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -14.211-10.436-12.881-10.461-10.707-7.899-10.636-10.11-17.059-19.042-38.837-19.926-17.275-9.622-12.267-5.059-5.091-8.89-3.011-3.406-1.958
Depreciation & Amortization -0.2480.0050.0050.0040.010.010.0090.010.010.010.0080.0050.0040.0050.0030.0060.0040.015000
Deferred Income Tax 00000-3.438-0.204-0.02200000-0.2830000000
Stock Based Compensation 0.9871.1771.1541.0470.9020.2840.8430.7441.4640.8590.8830.8370.6270.6890.6590.1580.0650.0160.0150.0120.009
Change In Working Capital 0-0.6753.6741.445-0.605-4.278-3.549-4.605-1.2580.334-6.3119.662.6070.0143.7011.023-4.4555.476-1.7310.7990.356
Accounts Receivables 000000000000000000000
Change In Inventory 000000000000000000000
Change In Accounts Payables -0.067-2.0732.288-0.091-0.072-3.134-1.5991.198-2.320.6974.3670.412-4.7650.2144.7480.015-5.0075.02-1.0621.0520.209
Other Working Capital 01.3981.3861.536-0.533-1.144-1.95-5.8032.32-0.363-10.6789.2487.372-0.2-1.0471.0080.5520.456-0.669-0.2530.147
Other Non Cash Items 0-0.273-0.3340.9061.8193.140.180.1720.012-0.010.074-0.0030.0130.283-4.0830.1555.085.035-1.0621.0520.209
Operating Cash Flow -12.711-10.202-8.382-8.205-9.575-12.181-13.357-13.811-16.831-17.849-44.183-9.427-14.024-8.914-7.904-3.872-9.477-3.383-4.727-2.595-1.593
Investing Activities:
Investments In Property Plant And Equipment 00-8.2058.20500000-0.086-0.086000000-0.071000
Acquisitions Net 00000000000.0860000000000
Purchases Of Investments 0-9.032-13.573-46.960-2.94-39.71700-13.819-13.248-5.974-79.27100000000
Sales Maturities Of Investments 23.75820.510.79.320.79.51.616.526.62526.716.3000000000
Other Investing Activites 008.205-37.660.0210.007-0.0380.0170.0270.086-0.0860.01-79.27100000000
Investing Cash Flow 23.75811.468-2.873-37.6620.76.56-38.11716.526.611.18113.36610.326-79.2710000-0.071000
Financing Activities:
Debt Repayment 000000000000000000000
Common Stock Issued 00014.55129.6560046.50300000.01991.9775.08591.977-0.01100.0200
Common Stock Repurchased -0.017-0.004-0.002-0.016-0.026-0.002-0.003-0.007-0.012-0.004-0.006-0.025000000000
Dividends Paid 000000000000000000000
Other Financing Activities 000.0120.1470.6200.031.2380.228029.5300.019-91.977091.977-0.01164.8260025.183
Financing Cash Flow -0.017-0.0040.0114.68230.25-0.0020.02747.7340.216-0.00429.524-0.0250.01905.08591.977-0.01164.8260.02025.183
Other Information:
Effect Of Forex Changes On Cash 00000-53.32653.32600000000000000
Net Change In Cash 11.031.262-11.245-31.18341.375-5.623-51.44750.4239.985-6.672-1.2930.874-93.276-8.914-2.81988.105-9.48861.372-4.707-2.59523.59
Cash At End Of Period 60.49449.46448.20259.44790.6349.25554.878106.32555.90245.91752.58953.88253.008146.284155.198158.01769.91279.418.02822.73525.33